Skip to search formSkip to main contentSkip to account menu

Sumatriptan

Known as: 1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide, Sumatriptán, 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide 
A sulfonamide triptan with vasoconstrictor activity. Sumatriptan selectively binds to and activates serotonin 5-HT1D receptors in the central nervous… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
This multicentre, doubleblind, parallel-group study compared the efficacy, safety and tolerability of oral sumatriptan, given as… 
2003
2003
Objectives.—To assess the impact of a group‐based model of disease management for patients with headache. 
Review
2000
Review
2000
5. Spierings ELH. Therapeutic gain: a critique. Headache 1999;39:517– 518. Letter. 6. Tfelt-Hansen P, Teall J, Rodriguez F, et al… 
Highly Cited
1995
Highly Cited
1995
We have used in vitro autoradiography to visualize [3H]sumatriptan binding sites in sections of guinea-pig and rat brain. In…